Vincent Levy, MD, PhD

head
Hôpital Avicenne, Département de Recherche Clinique, INSERM U1432, Hôpital Saint Louis, France

Poster(s):

• 1413 - A fixed-duration, chemo-sparing approach in CLL: 8-year results of the phase 2 ICLL-07 FILO trial

• 1504 - What measure of treatment effect should be preferred ? A critical review of 20 randomized clinical trials of targeted therapies in chronic lymphocytic leukemia

• 1521 - Real-world efficacy and safety of venetoclax +/- rituximab in >75-years old patients or with cardiovascular comorbidities and R/R chronic lymphocytic leukemia: interim results of the VERONE study